Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2016. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 96054801000001119 | Mepolizumab (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 96054901000001113 | Mepolizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mepolizumab | Is a | Monoclonal antibody agent | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mepolizumab 100mg powder for solution for injection vials | Has specific active ingredient | False | Mepolizumab | Inferred relationship | Existential restriction modifier | |
| Nucala 100mg powder for solution for injection vials (GlaxoSmithKline UK Ltd) | Has specific active ingredient | False | Mepolizumab | Inferred relationship | Existential restriction modifier | |
| Mepolizumab 100mg powder for solution for injection vials 1 vial | Has specific active ingredient | False | Mepolizumab | Inferred relationship | Existential restriction modifier | |
| Nucala 100mg powder for solution for injection vials (GlaxoSmithKline UK Ltd) 1 vial | Has specific active ingredient | False | Mepolizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR